Tricyclic antidepressant immunoassays may reflect quetiapine adherence

American Journal of Psychiatry

Volumn 165, Issue 7, 2008, Pages 919-920

  Cerullo, Michael A ^a   Albertz, Allison A ^a   Bell, Jennifer N ^a   Anthenelli, Robert M ^a   Delbello, Melissa P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; QUETIAPINE; STATUS DS; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT;

BIPOLAR MANIA; CANNABIS ADDICTION; CROSS REACTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG URINE LEVEL; FALSE POSITIVE RESULT; IMMUNOASSAY; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCREENING TEST; TREATMENT REFUSAL; URINALYSIS;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FRUCTOSE; HUMANS; IMMUNOASSAY; MARIJUANA ABUSE; PATIENT COMPLIANCE;

EID: 46749110363     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07060885     Document Type: Letter

References (5)

1. Sloan KL, Haver VM, Saxon AJ: Quetiapine and false-positive urine drug testing for tricyclic antidepressants. Am J Psychiatry 2000; 157:148-149
2. Hendrickson RG, Morocco AP: Quetiapine cross-reactivity among three tricyclic antidepressant immunoassays. J Toxicol Clin Toxicol 2003; 41:105-108
3. Caraveti EM, Juenke JM, Crouch BI, Anderson KT: Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays. Ann Pharmacother 2005; 39:1446-1449
4. Schwarz MJ: Therapeutic drug monitoring of quetiapine and its major metabolites quetiapine-sulfoxide and 7-hydroxy-quetiapine. Eur Psychiatry 2005; 20(suppl 1):S209
5. Kohnlein O, Lutz R, Schmau M, Messter T: Determining serum concentrations of the modern antipsychotic quetiapine: clinical relevance in therapeutic drug monitoring. Psychiatrische Praxis 2004; 31:S175-S177